Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial

被引:33
|
作者
Thirumurthy, Harsha [1 ,2 ]
Ndyabakira, Alex [3 ]
Marson, Kara [4 ]
Emperador, Devy [4 ]
Kamya, Moses [5 ]
Havlir, Diane [4 ]
Kwarisiima, Dalsone [3 ]
Chamie, Gabriel [4 ]
机构
[1] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA
[3] Infect Dis Res Collaborat, Kampala, Uganda
[4] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA
[5] Makerere Univ, Kampala, Uganda
来源
LANCET HIV | 2019年 / 6卷 / 03期
基金
美国国家卫生研究院;
关键词
ANTIRETROVIRAL THERAPY; IMPROVE ADHERENCE; LINKAGE; CARE;
D O I
10.1016/S2352-3018(18)30330-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Viral suppression among HIV-positive individuals is essential for protecting health and preventing HIV transmission. Financial incentives have shown promise in modifying various health behaviours in low-income countries but few studies have assessed whether they can improve HIV treatment outcomes. We aimed to determine the impact of time-limited financial incentives on viral suppression among HIV-positive adults in rural Uganda. Methods We did a randomised controlled trial in four rural Ugandan parishes. We recruited HIV-positive individuals (aged >= 18 years) from community health campaigns that included HIV testing services or at a local government health facility where HIV treatment is offered. Participants included those who were initiating antiretroviral therapy (ART) or already receiving ART. Eligibility to participate in the study did not depend on current ART or viral suppression status. Participants were randomly allocated (1: 1) to the financial incentive intervention or the control group in computer-generated blocks (block size 10 participants) and pre-printed scratch cards were used to reveal study group assignment. We measured participants' viral load at baseline and at weeks 6, 12, 24, and 48. At each timepoint, we provided results and viral load counselling. Participants in the intervention group received financial incentives for viral suppression at weeks 6, 12, and 24, with incentive amounts increasing from US$4 to $12.5. The primary outcome was viral suppression (viral load <400 copies per mL) at 24 weeks in the intention-to-treat population. Findings Between June 27, 2016, and May 25, 2018, we enrolled 400 adults in the study, of whom 203 were randomly assigned to the intervention group and 197 to the control group. Of these, 324 were enrolled from community health campaigns and 76 from the government clinic. Eight (2%) withdrew from the study and were not included in analyses. Over the 48-week follow-up period, 35 (9%) died or were lost-to-follow-up. Participants' median daily income was $0.79. At baseline, 300 participants (77%) were virally suppressed. In intention-to-treat analyses, 168 participants (84%) in the intervention group and 156 (82%) in the control group were virally suppressed at 24 weeks (odds ratio 1.14, 95% CI 0.68-1.93, p=0.62). Six participants (3%) in the control group and four (2%) in the intervention group had adverse events. Six of the adverse events were serious, including two deaths in the intervention group, three deaths in the control group, and one serious injury (tibia fracture) after an auto accident. No adverse events or deaths were related to study participation. Interpretation Financial incentives had no effect on viral suppression among HIV-positive adults. High baseline viral suppression and provision of viral load results might have contributed to high viral suppression among participants. These findings highlight the need for interventions that promote achievement of viral suppression among unsuppressed individuals.
引用
收藏
页码:E155 / E163
页数:9
相关论文
共 50 条
  • [21] Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART
    Zanoni, Brian C.
    Phungula, Thuli
    Zanoni, Holly M.
    France, Holly
    Feeney, Margaret E.
    AIDS, 2011, 25 (01) : 49 - 55
  • [22] Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial
    Chamie, Gabriel
    Hahn, Judith A.
    Kekibiina, Allen
    Emenyonu, Nneka, I
    Beesiga, Brian
    Marson, Kara
    Fatch, Robin
    Lodi, Sara
    Adong, Julian
    Thirumurthy, Harsha
    McDonell, Michael G.
    Gandhi, Monica
    Bryant, Kendall
    Havlir, Diane, V
    Kamya, Moses R.
    Muyindike, Winnie R.
    LANCET GLOBAL HEALTH, 2023, 11 (12): : E1899 - E1910
  • [23] A randomized controlled trial evaluating the effects of a family-centered HIV care model on viral suppression and retention in care of HIV-positive children in Eswatini
    Ashburn, Kim
    Chouraya, Caspian
    Khumalo, Philisiwe
    Mpango, Lydia
    Mthethwa, Nobuhle
    Machekano, Rhoderick
    Guay, Laura
    Mofenson, Lynne M.
    PLOS ONE, 2021, 16 (08):
  • [24] Directly Observed Antidepressant Medication Treatment and HIV Outcomes Among Homeless and Marginally Housed HIV-Positive Adults: A Randomized Controlled Trial
    Tsai, Alexander C.
    Karasic, Dan H.
    Hammer, Gwendolyn P.
    Charlebois, Edwin D.
    Ragland, Kathy
    Moss, Andrew R.
    Sorensen, James L.
    Dilley, James W.
    Bangsberg, David R.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2013, 103 (02) : 308 - 315
  • [25] Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use A Randomized Clinical Trial
    Metsch, Lisa R.
    Feaster, Daniel J.
    Gooden, Lauren
    Matheson, Tim
    Stitzer, Maxine
    Das, Moupali
    Jain, Mamta K.
    Rodriguez, Allan E.
    Armstrong, Wendy S.
    Lucas, Gregory M.
    Nijhawan, Ank E.
    Drainoni, Mari-Lynn
    Herrera, Patricia
    Vergara-Rodriguez, Pamela
    Jacobson, Jeffrey M.
    Mugavero, Michael J.
    Sullivan, Meg
    Daar, Eric S.
    McMahon, Deborah K.
    Ferris, David C.
    Lindblad, Robert
    VanVeldhuisen, Paul
    Oden, Neal
    Castellon, Pedro C.
    Tross, Susan
    Haynes, Louise F.
    Douaihy, Antoine
    Sorensen, James L.
    Metzger, David S.
    Mandler, Raul N.
    Colfax, Grant N.
    del Rio, Carlos
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (02): : 156 - 170
  • [26] Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial
    Parkes-Ratanshi, Rosalind
    Wakeham, Katie
    Levin, Jonathan
    Namusoke, Deodata
    Whitworth, James
    Coutinho, Alex
    Mugisha, Nathan Kenya
    Grosskurth, Heiner
    Kamali, Anatoli
    Lalloo, David G.
    LANCET INFECTIOUS DISEASES, 2011, 11 (12): : 933 - 941
  • [27] Financial Incentives to Increase Uptake of Pediatric HIV Testing (FIT): study protocol for a randomised controlled trial in Kenya
    Wagner, Anjuli D.
    Njuguna, Irene N.
    Neary, Jillian
    Omondi, Vincent O.
    Otieno, Verlinda A.
    Babigumira, Joseph
    Maleche-Obimbo, Elizabeth
    Wamalwa, Dalton C.
    John-Stewart, Grace C.
    Slyker, Jennifer A.
    BMJ OPEN, 2018, 8 (10):
  • [28] Perceived neighborhood disorder and achieving HIV viral suppression among adults living with HIV: A cross-sectional study
    Kimaru, Linda Jepkoech
    Hu, Chengcheng
    Nagalingam, Sudha
    Magrath, Priscilla
    Connick, Elizabeth
    Ernst, Kacey
    Ehiri, John
    PLOS GLOBAL PUBLIC HEALTH, 2024, 4 (12):
  • [29] Increased levels of current alcohol use are associated with worse HIV care cascade outcomes among HIV-positive adults in rural Kenya and Uganda in the SEARCH trial
    Puryear, S.
    Ayieko, J.
    Kwarisiima, D.
    Hahn, J. A.
    Balzer, L. B.
    Charlebois, E. D.
    Clark, T.
    Cohen, C. R.
    Bukusi, E. A.
    Kamya, M. R.
    Petersen, M.
    Havlir, D.
    Chamie, G.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 58 - 58
  • [30] EVALUATING THE IMPACT OF SHORT TERM FINANCIAL INCENTIVES ON HIV AND STI INCIDENCE AMONG YOUTH IN LESOTHO: A RANDOMISED TRIAL
    Bjorkman-Nyqvist, M.
    Corno, L.
    de Walque, D.
    Svensson, J.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A325 - A325